Fractyl Health outlines 2026 De Novo submission plans with pivotal Revita data expected in early Q4 (NASDAQ:GUTS)


Follow us on Google for the latest stock news

Earnings Call Insights: Fractyl Health (GUTS) Q4 2025

Management View

  • CEO Harith Rajagopalan emphasized the company’s conviction in the Revita platform for post-GLP-1 weight maintenance, stating, “Revita is being built for that moment. For those of you who are new to the Fractyl

Seeking Alpha’s Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.



Source link

Comfy, Lightweight Styles to Shop

Steph Curry Celebrates Ayesha Curry’s 37th Birthday, Fans React

Leave a Reply

Your email address will not be published. Required fields are marked *